Breast milk cellular HIV-specific interferon γ responses are associated with protection from peripartum HIV transmission

AIDS

Volumn 26, Issue 16, 2012, Pages 2007-2016

  Lohman Payne, Barbara ^a,b,c   Slyker, Jennifer A ^a,b   Moore, Stephen ^a   Maleche Obimbo, Elizabeth ^c   Wamalwa, Dalton C ^c   Richardson, Barbra A ^b,e   Rowland Jones, Sarah ^d   Mbori Ngacha, Dorothy ^c   Farquhar, Carey ^a,b   Overbaugh, Julie ^e   John Stewart, Grace ^a,b  

^a UNIVERSITY OF WASHINGTON   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c UNIVERSITY OF NAIROBI   (Kenya)

^d UNIVERSITY OF OXFORD   (United Kingdom)

^e Fred Hutchinson Cancer Research Center   (United States)

Author keywords

breast milk cytotoxic T lymphocytes; breastfeeding; cytokines; early postnatal transmission; infant; MIP 1b; pediatric; sub Saharan Africa

Indexed keywords

GAMMA INTERFERON; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; STROMAL CELL DERIVED FACTOR 1;

ADULT; ARTICLE; BLOOD ANALYSIS; BREAST MILK; CELLULAR IMMUNITY; CORRELATION ANALYSIS; ENZYME LINKED IMMUNOSPOT ASSAY; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFANT; INFECTION PREVENTION; MAJOR CLINICAL STUDY; PERINATAL PERIOD; PREVALENCE; PRIORITY JOURNAL; T LYMPHOCYTE; VERTICAL TRANSMISSION; VIRUS LOAD; VIRUS REPLICATION;

ADULT; BREAST FEEDING; CD8-POSITIVE T-LYMPHOCYTES; FEMALE; HIV SEROPOSITIVITY; HIV-1; HUMANS; INFANT, NEWBORN; INFECTIOUS DISEASE TRANSMISSION, VERTICAL; INTERFERON-GAMMA; KENYA; MALE; MILK, HUMAN; PERIPARTUM PERIOD; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; PROSPECTIVE STUDIES; VIRAL LOAD;

EID: 84867740442     PISSN: 02699370     EISSN: 14735571     Source Type: Journal    
DOI: 10.1097/QAD.0b013e328359b7e0     Document Type: Article

References (44)

1. John-Stewart G, Mbori-Ngacha D, Ekpini R, Janoff EN, Nkengasong JN, Read JS, et al. Breast-feeding and transmission of HIV-1. J Acquir Immune Defic Syndr 2004; 35:196-202.
2. Nduati R, John GC, Mbori-Ngacha D, Richardson BA, Over-baugh J, Mwatha A, et al. Effect of breastfeeding and formula feeding on transmission of HIV-1: a randomized clinical trial. JAMA 2000; 283:1167-1174.
3. Bosire R, Guthrie BL, Lohman-Payne BL, Mabuka JM, Majiwa M, Wariua G, et al. Longitudinal comparison of chemokines in breastmilk early postpartum among HIV-1 infected and unin-fected Kenyan women. Breastfeeding Med 2007; 2:129-138.
4. Hawkes JS, Bryan D-L, Gibson RA. Cytokine production by human milk cells and peripheral blood mononuclear cells from the same mothers. J Clin Immunol 2002; 22:338-344.
5. Ichikawa M, Sugita M, Takahashi M, Satomi M, Takeshita T, Araki T, Takahashi H. Breast milk macrophages spontaneously produce granulocyte- macrophage colony-stimulating factor and differentiate into dendritic cells in the presence of exogenous interleukin-4 alone. Immunology 2003; 108:189-195.
6. Becquart P, Petitjean G, Al Tabaa Y, Valea D, Huguet M-F, Tuaillon E, et al. Detection of a large T-cell reservoir able to replicate HIV-1 actively in breast milk. AIDS 2006; 20:1453-1462.
7. Petitjean G, Becquart P, Tuaillon E, Al Tabaa Y, Valea D, Huguet M-F, et al. Isolation and characterization of HIV-1-infected resting CD4R T lymphocytes in breast milk. J Clin Virol 2007; 39:1-8.
8. Kourtis AP, Ibegbu C, Theiler R, Xu Y-X, Bansil P, Jamieson DJ, et al. Breast milk CD4R T cells express high levels of chemokine receptor 5 and CXC chemokine receptor4and are preserved in HIV-infected mothers receiving highly active antiretroviral therapy. J Infect Dis 2007; 195:965-972.
9. Sabbaj S, Edwards BH, Ghosh MK, Semrau K, Cheelo S, Thea DM, et al. Human immunodeficiency virus-specific CD8R T cells in human breast milk. J Virol 2002; 76:7365-7373.
10. Sabbaj S, Ghosh MK, Edwards BH, Leeth R, Decker WD, Goepfert PA, Aldrovandi GM. Breast milk-derived antigen-specific CD8R T cells: an extralymphoid effector memory cell population in humans. J Immunol 2005; 174:2951-2956.
11. Tuaillon E, Valea D, Becquart P, Al Tabaa Y, Meda N, Bollore K, et al. Human milk-derived B cells: a highly activated switched memory cell population primed to secrete antibodies. J Immunol 2009; 182:7155-7162.
12. Lohman BL, Slyker J, Mbori-Ngacha D, Bosire R, Farquhar C, Obimbo E, et al. Prevalence and magnitude of human immunodeficiency virus (HIV) type 1-specific lymphocyte responses in breast milk from HIV-1-seropositive women. J Infect Dis 2003; 188:1666-1674.
13. Mahlokozera T, Kang HH, Goonetilleke N, Stacey AR, Lovingood RV, Denny TN, et al. The magnitude and kinetics of the mucosal HIV-specific CD8R T lymphocyte response and viral RNA load in breast milk. PLoS One 2011; 6:e23735.
14. Rousseau CM, Nduati RW, Richardson BA, John-Stewart GC, Mbori-Ngacha DA, Kreiss JK, Overbaugh J. Association of levels of HIV-1-infected breast milk cells and risk of mother-to-child transmission. J Infect Dis 2004; 190:1880-1888.
15. Otieno PA, Brown ER, Mbori-Ngacha DA, Nduati RW, Farquhar C, Obimbo EM, et al. HIV-1 disease progression in breastfeeding and formula-feeding mothers: A prospective 2-year comparison of T cell subsets, HIV-1 RNA levels, and mortality. J Infect Dis 2007; 195:220-229.
16. John-Stewart GC, Mbori-Ngacha D, Lohman-Payne B, Farquhar C, Richardson BA, Emery S, et al. HIV-1-specific cytotoxic T lymphocytes and breast milk HIV-1 transmission. J Infect Dis 2009; 199:889-898.
17. Shaffer N, Chuahchoowong R, Mock PA, Bhadrakom C, Siriwasin W, Young NL, et al. Short-course zidovudine for perinatal HIV-1 transmission in Bangkok, Thailand: a randomized clinical trial. Bangkok Collaborative Perinatal HIV Transmission Study Group. Lancet 1999; 353:773-780.
18. Emery S, Bodrug S, Richardson BA, Giachetti C, Bott MA, Panteleeff D, et al. Evaluation of performance of the Gen-Probe human immunodeficiency virus type 1 viral load assay using primary subtype A, C, and D isolates from Kenya. J Clin Microbiol 2000; 38:2688-2695.
19. Devange PD, Emery S, Richardson BA, Rousseau C, Benki S, Bodrug S, et al. Validation of performance of the Gen-Probe human immunodeficiency virus type 1 viral load assay with genital swabs and breast milk samples. J Clin Microbiol 2002; 40:3929-3937.
20. Mwau M, Cebere I, Sutton J, Chikoti P, Winstone N, Wee EG-T, et al. Ahumanimmunodeficiencyvirus1(HIV-1)cladeAvaccine in clinical trials: stimulation of HIV-specific T-cell responses by DNA and recombinant modified vaccina virus Ankara (MVA) vaccines in humans. J Gen Virol 2004; 85:911-919.
21. Mwau M, McMichael AJ, Hanke T. Design and validation of an enzyme-linked immunospot assay for use in clinical trials of candidate HIV vaccines. AIDS Res Hum Retroviruses 2002; 18:611-618.
22. Kaul R, Rowland-Jones SL. Methods of detection of HIV-spe-cific CTL and their role in protection against HIV infection. In: HIV Immunology Database. Los Alamos, NM: Theoretical Biology and Biophysics; 1999. pp. 27-36.
23. DeVange PD, John GC, Nduati R, Mbori-Ngacha D, Richardson BA, Kreiss JK, Overbaugh J.Rapid method for screening dried blood samples on filter paper for human immunodeficiency virus type 1 DNA. J Clin Microbiol 1999; 37:350-353.
24. Filteau S. The influence of mastitis on antibody transfer to infants through breast milk. Vaccine 2003; 21:3377-3381.
25. Farquhar C, Mbori-Ngacha DA, Redman MW, Bosire RK, Lohman BL, Piantadosi AL, et al. CC and CXC chemokines in breastmilk are associated with mother-to-child HIV-1 transmission. Current HIV Res 2005; 3:361-369.
26. Holm S. A simple sequentially rejective multiple test procedure. Scand J Stat 1979; 6:65-70.
27. Rousseau CM, Nduati RW, Richardson BA, Steele MS, John-Stewart GC, Mbori-Ngacha DA, et al. Longitudinal analysis of human immunodeficiency virus type 1 RNA in breast milk and of its relationship to infant infection and maternal disease. J Infect Dis 2003; 187:741-747.
28. Mattapallil JJ, Smit-McBride Z, McChesney MB, Dandekar S. Intestinal intraepithelial lymphocytes are primed for gamma interferon and MIP-1b expression and display antiviral cytotoxic activity despite severe CD4R T-cell depletion in primary simian immunodeficiency virus infection. J Virol 1998; 72:6421-6429.
29. Appay V, Nixon DF, Donahoe SM, Gillespie GMA, Dong T, King A, et al. HIV-specific CD8R T cells produce antiviral cytokines but are impaired in cytolytic function. J Exp Med 2000; 192:63-75.
30. Cocchi F, DeVico AL, Yarchoan R, Redfield R, Cleghorn F, Blattner WA, et al. Higher macrophage inflammatory protein (MIP)-1a and MIP-1b levels from CD8R T cells are associated with asymptomatic HIV-1 infection. Proc Natl Acad Sci USA 2000; 97:13812-13817.
31. Ferre AL, Hunt PW, Critchfield JW, Young DH, Morris MM, Garcia JC, et al. Mucosal immune responses to HIV-1 in elite controllers: a potential correlate of immune control. Blood 2009; 113:3978-3989.
32. Kamin-Lewis R, Abdelwahab SF, Trang c, Baker A, DeVico AL, Gallo RC, Kewis GK. Perforin-low memory CD8R cells are the predominant T cells in normal humans that synthesize the b-chemokine macrophage inflammatory protein-1b. Proc Natl Acad Sci USA 2001; 98:9283-9288.
33. Weiler IJ, Hickler W, Sprenger R. Demonstration that milk cells invade suckling neonatal mice. Am J Repro Immunol 1983; 4:95-98.
34. Jain L, Vidyasagar D, Xanthou M, Ghai V, Shimada S, Blend M. In vivo distribution of human milk leucocytes after ingestion by newborn baboons. Arch Dis Child 1989; 64:923-930.
35. Kumar SN, Stewart GL, Steven WM, Seelig LL. Maternal to neonatal transmission of T-cell mediated immunity to Trichi-nella sprialis during lactation. Immunol 1989; 68:87-92.
36. Ogra SS, Ogra PL. Immunologic aspects of human colostrum and milk. II: Characteristics of lymphocyte reactivity and distribution of E-rossete forming cells at different times after the onset of lactation. J Pediat 1978; 92:550-555.
37. van de Perre P. Breast milk transmission of HIV-1. Laboratory and clinical studies. Ann N Y Acad Sci 2000; 918:122-127.
38. Southern S, Southern P. Cellular mechanism for milk-borne transmission of HIV and HTLV. In: David EA, editor. Integrating population outcomes, biological mechanisms and research methods in the study of human milk and lactation. New York: Kluwer Academic/Plenum Publishers; 2002. pp. 183-190.
39. Buseyne F, Le Chenadec J, Corre B, Porrot F, Burgard M, Rouzioux C, et al. Inverse correlation between memory gag-specific cytotoxic T lymphocytes and viral replication in human immunodeficiency virus-infected children. J Infect Dis 2002; 186:1589-1596.
40. Chouquet C, Autran B, Gomard E, Bouley J-M, Calvez V, Katlama C, et al. Correlation between breadth of memory HIV-specific cytotoxic T cells, viral load and disease progression in HIV infection. AIDS 2002; 16:2399-2407.
41. Edwards BH, Bansal A, Sabbaj S, Bakari J, Mulligan MJ, Goepfert PA. Magnitude of functional CD8R T-cell responses to the gag protein of human immunodeficiency virus type 1 correlates inversely with viral load in plasma. J Virol 2002; 76:2298-2305.
42. Mollet L, Li T-S, Samri A, Tournay C, Tubiana R, Calvez V, et al. Dynamics of HIV-specific CD8R T lymphocytes with changes in viral load. J Immunol 2000; 165:1692-1704.
43. Novitsky V, Gilbert P, Peter T, McLane MF, Gaolekwe S, Rybak N, et al. Association between virus-specific T-cell responses and plasma viral load in human immunodeficiency virus type 1 subtype C infection. J Virol 2003; 77:882-890.
44. Patke DS, Langan SJ, Carruth LM, Keating SM, Sabundayo BP, Margolick JB, et al. Association of gag-specific T lymphocyte responses during the early phase of human immunodeficiency virus type 1 infection and lower virus set point. J Infect Dis 2002; 186:1177-1180.